Diagnostic BioSystems
Diagnostic BioSystems is a privately held, US-based specialty manufacturer of immunohistochemistry reagents, detection systems, chromogens, and automated staining instruments, serving clinical pathology labs, hospitals, and research institutions in over 85 countries.
- Company typePrivate
- Founded1994
- HeadquartersPleasanton, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Diagnostic BioSystems does
Diagnostic BioSystems (DBS) is a privately held US specialty manufacturer of immunohistochemistry (IHC) and immunofluorescence reagents, founded in 1994 and headquartered in Pleasanton, California. The company builds a vertically integrated portfolio of anatomic pathology products covering primary antibodies (rabbit and mouse monoclonals), FITC conjugates, proprietary HRP and alkaline phosphatase detection systems (PolyVue Plus, UnoVue, Moh's HRP), a broad chromogen line (DAB, PermaRed/Blue/Green/Yellow/Black, AEC), antigen retrieval buffers, special stains, ancillary reagents, and two key instruments: the DBS HighLighter 360 Autostainer and the Montage Opus365 antigen retrieval system, with associated consumables such as the HighLighter Core Kit and SlideMaster365. Manufacturing is governed by FDA 21 CFR Part 820, ISO 13485:2016, CE marking under EU IVDR, and a 2025 SFDA approval, with products sold in IVD (US and ex-US) and RUO formats.
The company sells primarily through a multi-channel model that combines direct regional sales offices in Germany, Mexico, India, and Canada with a global network of authorized distributors in 85+ countries, including Cardinal Health Scientific, ThermoFisher Scientific, ESBE Scientific, and Leader Life Sciences UAE. Its 100%-owned subsidiary, Diagnostic BioSystems USA Pvt. Ltd. (Secunderabad, India), drives South Asia expansion and was recognized as the fastest growing molecular diagnostic company in India at the 2025 Growth Stories Summit. Pricing is quote-based and not publicly disclosed, and revenue is generated from one-time sales of reagents, instruments, and consumables to hospitals, clinical pathology labs, dermatology and Mohs surgery centers, and academic research institutions. The company is led by founder Bipin Gupta (CEO and CSO) and has a small management bench of regional sales heads, with no disclosed external institutional ownership beyond a historical 2015 relationship with BroadOak Capital Partners.
Diagnostic BioSystems firmographics
Firmographics- Name
- Diagnostic BioSystems
- Legal name
- Diagnostic BioSystems Inc.
- Website
- https://dbiosys.com
- Company type
- Private
- Founded year
- 1994
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Diagnostic BioSystems is a privately held, US-based specialty manufacturer of immunohistochemistry reagents, detection systems, chromogens, and automated staining instruments, serving clinical pathology labs, hospitals, and research institutions in over 85 countries.
- Ownership category
- akta.pro rank
Diagnostic BioSystems industry classification
Industry- Product category
- Anatomic Pathology Diagnostics
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL)
- akta.pro secondary industries
- Clinical Chemistry & Immunoassay Systems (HLAHAAAA), Anatomic Pathology & Histopathology (Trial Support) (HLAGAEAC)
Keywords
Where Diagnostic BioSystems is headquartered
LocationHeadquarters
- HQ city
- Pleasanton
- HQ country
- United States
- HQ region
- North America
Offices5 records
Markets served
Diagnostic BioSystems business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Infrastructure
Revenue model
- IHC Reagents and Antibodies: DBS generates revenue through the sale of primary antibodies, FITC conjugated antibodies, and related reagents for immunohistochemistry and immunofluorescence applications. Products are sold as IVD (in vitro diagnostic) and RUO (research use only) formats.
- Detection Systems and Chromogens: Sale of detection kits (HRP/DAB, AP-based), chromogens (DAB, AEC, PermaRed series), and related consumables for IHC staining procedures.
- Instrumentation: Sale of automated staining instruments including DBS HighLighter 360 Autostainer and Montage Opus365 antigen retrieval system, along with consumable kits and accessories.
- Specialty Stains and Ancillaries: Revenue from special histology stains (Masson's Trichrome, Papanicolaou, Steiner, etc.), mounting media, buffers, blockers, and other ancillary reagents.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | IVD products for US market - FDA registered medical devices |
| One time/ perpetual license | Pay-as-you-go | IVD products for outside US market - CE marked |
| One time/ perpetual license | Pay-as-you-go | RUO (Research Use Only) products |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels6 records
Diagnostic BioSystems product offering
Product offeringCore offering
Diagnostic BioSystems manufactures and sells a comprehensive portfolio of immunohistochemistry (IHC) and immunofluorescence products for anatomic pathology diagnostics. Its offerings include primary antibodies (rabbit and mouse monoclonal), FITC-conjugated antibodies, HRP and AP detection systems (UnoVue, PolyVue Plus, Moh's kits), a full line of chromogens, ancillary reagents, antigen retrieval solutions, and special histology stains. The company also produces and sells automated instrumentation, notably the DBS HighLighter 360 Autostainer and the Montage Opus365 antigen retrieval system, along with associated consumables.
Product overview
Diagnostic BioSystems (DBS) is a global IHC company that provides a comprehensive portfolio of anatomic pathology reagents and automated instrumentation for immunohistochemistry (IHC) and immunofluorescence testing. The product portfolio centers on primary antibodies (rabbit monoclonal and mouse monoclonal), detection systems (UnoVue HRP Kit, PolyVue Plus HRP/DAB Kit, Moh's HRP Detection Kit, Universal HRP Immunostaining Kit), and an extensive chromogen line (DAB, PermaRed, PermaBlue, PermaGreen, PermaYellow, PermaBlack variants) for HRP and alkaline phosphatase detection. Supporting products include antigen retrieval solutions (citrate and Tris-EDTA buffers at various pH levels), ancillary reagents (mounting media, blockers, wash buffers), special stains, and the Elite PAP Pen. DBS also offers two key instrumentation platforms: the DBS Highlighter 360 Autostainer for automated slide staining and the Montage Opus365 for antigen retrieval, along with associated consumables including the HighLighter Core Kit and SlideMaster365. The company serves clinical pathology laboratories globally with FDA-registered IVD products for the US market and CE-marked devices for international markets.
Differentiator
Problem solved
Functional benefit
Brands
- UnoVue: One-step HRP detection system for immunohistochemistry
- PolyVue Plus
- Montage Opus365
- DBS Highlighter 360
- SlideMaster365
- CF488
Products and services
- Primary Antibodies Rabbit monoclonal and mouse monoclonal antibodies for immunohistochemistry testing, available in IVD (US and outside-US) and RUO formats for detecting tumor markers in cancer diagnostics.
- FITC Antibodies Fluorescein isothiocyanate (FITC) conjugated antibodies for immunofluorescence applications in cancer diagnostics.
- UnoVue HRP Kit One-step detection system for mouse and rabbit primary antibodies using HRP/DAB chemistry, designed for rapid immunohistochemistry staining.
- PolyVue Plus HRP/DAB Kit Two-step detection system for mouse and rabbit primary antibodies using HRP/DAB chemistry, providing optimal staining for both antibody types.
- Moh's HRP Detection Kit HRP-based detection system specifically designed for Mohs surgery applications, producing green color for rapid tissue analysis.
- Universal HRP Immunostaining Kit RTU immunostaining kit for qualitative immunohistochemistry with mouse and rabbit primary antibodies on formalin-fixed paraffin-embedded tissue sections.
- DBS HighLighter 360 Autostainer Fully automated slide staining system for high-throughput immunohistochemistry and immunofluorescence testing in clinical laboratories.
- Montage Opus365 Antigen retrieval system designed for automated and standardized heat-induced epitope retrieval prior to immunohistochemistry staining.
- HighLighter Core Kit Core kit containing essential reagents (dewax solutions, citrate buffer, EDTA buffer, tissue primer, background blocker, DAB Auto) for the DBS HighLighter 360 Autostainer.
- SlideMaster365 Slide organization and management system for laboratory workflow optimization in immunohistochemistry testing.
- Chromogens (DAB, PermaRed, PermaBlue, PermaGreen, PermaYellow, PermaBlack, AEC) Comprehensive line of chromogen substrates for HRP and alkaline phosphatase detection systems, producing various colors (brown, red, blue, green, yellow, black) for single and multiplex immunohistochemistry staining.
- Antigen Retrieval Solutions Buffers (citrate, Tris-EDTA, EDTA) at various pH levels designed for heat-induced epitope retrieval (HIER) to restore antigenicity in formalin-fixed paraffin-embedded tissue sections.
- Ancillary Reagents Supporting products including mounting media (CC/Mount, Fluoromount), blockers (peroxidase block, background blocker), wash buffers, tissue adhesive, and other accessories for immunohistochemistry workflows.
- Special Stains Histological staining kits for connective tissue, collagen, microorganisms, and specialized tissue analysis including reticulum stain, trichrome stain, Steiner stain, and various special purpose stains.
- Elite PAP Pen Hydrophobic barrier pen that creates a water-repellent circle around tissue specimens to hold antibody solution during staining procedures.
- Montage DAB Gone Kit DAB stain removal and decontamination kit that chemically inactivates DAB residue from instrument probes, tubing, and glassware; also designed for cleaning DBS Montage 360 and compatible autostainers.
- CF488 Cyanine-based fluorescent dye conjugates for immunofluorescence applications in cancer diagnostics.
- Intensi/Fire Signal enhancer that increases DAB staining intensity in immunohistochemistry when applied after brief incubation, providing improved sensitivity.
- Alkaline Phosphatase Enhancer Signal enhancement solution that increases alkaline phosphatase signal several fold for improved detection in immunohistochemistry and in situ hybridization.
Quantifiable outcome
- Consistent high quality and short-term availability across product portfolio
- +2 more outcomes
Companies that use Diagnostic BioSystems
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles3 records
Diagnostic BioSystems technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration5 records
Feature6 records
Diagnostic BioSystems partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and regional.
- Cardinal Health ScientificcorePartnership established in 2025 for distribution of Diagnostic BioSystems products, expanding market reach in the healthcare distribution sector.
- ESBE ScientificcoreEstablished partnership for distribution of DBS IHC reagents in specific regions, providing complementary product offerings to customers.
- ThermoFisher ScientificcoreStrategic partnership in USA for IHC product distribution and market access, leveraging ThermoFisher's extensive laboratory products distribution network.
- Leader Life Sciences UAEregionalAuthorized distributor for UAE and Middle East region, expanding DBS presence in the Gulf Cooperation Council markets.
Scale indicators3 records
Recent moves6 records
Expansion highlights6 records
Diagnostic BioSystems competitors and assessment
Company assessmentDirect peers
- Cell Marque (Merck KGaA / MilliporeSigma): Focused IHC antibody vendor with a deep catalog of ready-to-use clinical IHC reagents, now part of the life science tools business of Merck KGaA. Directly comparable in primary antibody and detection kit focus.
- Biocare Medical: Specialty IHC and multiplexing reagent company with a comparable product line of primary antibodies, detection systems, chromogens, and the intelliPATH autostainer referenced in DBS's integration materials. Closest head-to-head competitor in mid-sized IHC reagent vendors.
- Abcam: Large antibody reagent company serving research and diagnostic customers globally. Comparable in primary antibody development and IVD/RUO dual-format commercialization, though Abcam is much larger and research-skewed.
- Vector Laboratories: Specialty IHC detection systems and reagent company historically known for VECTASTAIN ABC kits and ImmPRESS polymer detection, a direct analog of DBS's PolyVue Plus and UnoVue HRP kits.
- Sakura Finetek: Histology and IHC instrumentation and reagent company offering integrated tissue processing and autostaining platforms. Comparable in instrument + reagent go-to-market approach for anatomic pathology.
Broad incumbents
- Leica Biosystems (Danaher): Major anatomic pathology vendor offering the BOND-III IHC/ISH stainer and a full reagent portfolio, representing a closed-workflow incumbent against which DBS's open-platform reagents compete.
- Roche Diagnostics (Ventana): Operates the Ventana IHC portfolio (BenchMark instruments, OptiView/ultraView detection), the largest closed IHC workflow globally. Sets the competitive ceiling DBS must work around in hospital accounts.
- Bio-Techne: Life science tools company with an IHC and spatial biology reagent portfolio (including ACD RNAscope and ProteinSimple). Comparable in serving both research and clinical pathology customers.
- Agilent Technologies (DAKO): Owns the DAKO IHC franchise, including the Omnis and Autostainer platforms DBS products are validated against. The dominant large-cap incumbent in anatomic pathology and a key reference standard for DBS.
Emerging players
- StatLab Medical Products: Mid-sized histology and IHC reagent and consumables company that has been building out an IHC antibody and detection portfolio through M&A. Comparable in product scope and channel-based distribution model.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Diagnostic BioSystems social profiles
Digital presenceDiagnostic BioSystems compliance and trust
Trust signalCompliance3 records
Diagnostic BioSystems financial estimates
Financial estimateRevenue estimate
Valuation estimate
Diagnostic BioSystems leadership team
Management profileNumber of profiles
Profiles5 records
Diagnostic BioSystems subsidiaries and ownership
Company hierarchySubsidiaries1 record
Diagnostic BioSystems funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Diagnostic BioSystems M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Diagnostic BioSystems
What does Diagnostic BioSystems do?
Diagnostic BioSystems manufactures and sells a comprehensive portfolio of immunohistochemistry (IHC) and immunofluorescence products for anatomic pathology diagnostics. Its offerings include primary antibodies (rabbit and mouse monoclonal), FITC-conjugated antibodies, HRP and AP detection systems (UnoVue, PolyVue Plus, Moh's kits), a full line of chromogens, ancillary reagents, antigen retrieval solutions, and special histology stains. The company also produces and sells automated instrumentation, notably the DBS HighLighter 360 Autostainer and the Montage Opus365 antigen retrieval system, along with associated consumables.
Is Diagnostic BioSystems a public or private company?
Diagnostic BioSystems is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Diagnostic BioSystems founded?
Diagnostic BioSystems was founded in 1994. It employs 11 to 50 people.
Where is Diagnostic BioSystems based?
Diagnostic BioSystems is headquartered in Pleasanton, United States, in the North America region.
How does Diagnostic BioSystems make money?
Four revenue lines are on record. IHC Reagents and Antibodies are the primary driver. The others are detection Systems and Chromogens, instrumentation and specialty Stains and Ancillaries.
Who are Diagnostic BioSystems's main competitors?
Direct peers on record are Cell Marque (Merck KGaA / MilliporeSigma), Biocare Medical, Abcam, Vector Laboratories and Sakura Finetek. Broad incumbents are Leica Biosystems (Danaher), Roche Diagnostics (Ventana), Bio-Techne and Agilent Technologies (DAKO). StatLab Medical Products is listed as an emerging player.
Does Diagnostic BioSystems have an API?
No public API is recorded for Diagnostic BioSystems.
What industry is Diagnostic BioSystems in?
Diagnostic BioSystems's product category is Anatomic Pathology Diagnostics. Its primary akta.pro industry code is HLAAAMAL, Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls), with a secondary code of HLAHAAAA, Clinical Chemistry & Immunoassay Systems. Its NAICS code is 325413 and its SIC code is 2835.